Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Hawes

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Neurorehabilitation|November 25, 2010
Evaluation and treatment of some common medical eye conditions encountered in patients with TBI, stroke and other neurological conditions in an acute care rehabilitation hospitalBrian Joondeph, Michael Hawes, Thomas Politzer
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|November 19, 2010
Evaluation of porcine hydrated dermis augmented repair in a fascial defect modelEileen S Hackett, Dina Harilal, Chris Bowley, et al.
Immunopharmacology and Immunotoxicology|June 6, 2003
Minimal effects on immune parameters following chronic anti-TGF-beta monoclonal antibody administration to normal miceMelanie C Ruzek, Michael Hawes, Bruce Pratt, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|November 14, 2017
Evaluation of a bioengineered construct for tissue engineering applicationsPerla Ayala, Erbin Dai, Michael Hawes, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2009
Pyrazole NNRTIs 3: optimisation of physicochemical propertiesCharles E Mowbray, Romuald Corbau, Michael Hawes, et al.
Molecular Genetics and Metabolism|August 6, 2014
Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeuticsJames M Murray, Anne Marie Thompson, Allison Vitsky, et al.
Journal of Shoulder and Elbow Surgery|August 12, 2019
A prospective study comparing tendon-to-bone interface healing using an interposition bioresorbable scaffold with a vented anchor for primary rotator cuff repair in sheepJeremiah Easley, Christian Puttlitz, Eileen Hackett, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2009
Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidateCharles E Mowbray, Catherine Burt, Romuald Corbau, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2024
Reply to Muralidhar et al., Kenny et al., and Hotz et al.: The benefits of engagement with external research teamsRon S Jarmin, John M Abowd, Robert Ashmead, et al.
Molecular Therapy. Nucleic Acids|November 6, 2023
Efficacy and safety of a SOD1-targeting artificial miRNA delivered by AAV9 in mice are impacted by miRNA scaffold selectionShukkwan K Chen, Zachary C E Hawley, Maria I Zavodszky, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Neurorehabilitation|November 25, 2010
Evaluation and treatment of some common medical eye conditions encountered in patients with TBI, stroke and other neurological conditions in an acute care rehabilitation hospitalBrian Joondeph, Michael Hawes, Thomas Politzer
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|November 19, 2010
Evaluation of porcine hydrated dermis augmented repair in a fascial defect modelEileen S Hackett, Dina Harilal, Chris Bowley, et al.
Immunopharmacology and Immunotoxicology|June 6, 2003
Minimal effects on immune parameters following chronic anti-TGF-beta monoclonal antibody administration to normal miceMelanie C Ruzek, Michael Hawes, Bruce Pratt, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials|November 14, 2017
Evaluation of a bioengineered construct for tissue engineering applicationsPerla Ayala, Erbin Dai, Michael Hawes, et al.
Bioorganic & Medicinal Chemistry Letters|September 1, 2009
Pyrazole NNRTIs 3: optimisation of physicochemical propertiesCharles E Mowbray, Romuald Corbau, Michael Hawes, et al.
Molecular Genetics and Metabolism|August 6, 2014
Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency:the utility of animal models of disease in the toxicological evaluation of potential therapeuticsJames M Murray, Anne Marie Thompson, Allison Vitsky, et al.
Journal of Shoulder and Elbow Surgery|August 12, 2019
A prospective study comparing tendon-to-bone interface healing using an interposition bioresorbable scaffold with a vented anchor for primary rotator cuff repair in sheepJeremiah Easley, Christian Puttlitz, Eileen Hackett, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2009
Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidateCharles E Mowbray, Catherine Burt, Romuald Corbau, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 5, 2024
Reply to Muralidhar et al., Kenny et al., and Hotz et al.: The benefits of engagement with external research teamsRon S Jarmin, John M Abowd, Robert Ashmead, et al.
Molecular Therapy. Nucleic Acids|November 6, 2023
Efficacy and safety of a SOD1-targeting artificial miRNA delivered by AAV9 in mice are impacted by miRNA scaffold selectionShukkwan K Chen, Zachary C E Hawley, Maria I Zavodszky, et al.
Pageof 1